Has there been a shift in how the European courts approach preliminary injunctions?
von Dr Paul England und Christoph de Coster, LL.M. (UC Davis)
AI driven drug design
Unpacking the role of AI in bringing new drugs to market.
von Dr Paul England
1 von 6 Insights
The EU torpedoes itself in cross-border patent disputes
von Dr Paul England
Paul England and Simon Cohen launch new life sciences IP guide
von Dr Paul England und Simon Cohen
Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies
von mehreren Autoren
Edison Open House Global Healthcare 2021 – key takeaways from our panel
von mehreren Autoren
Will the UK government's COVID-19 dosing regime gamble pay off?
von Alison Dennis und Justyna Ostrowska
What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies
von Alison Dennis
8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021
von Alison Dennis und Dr Paul England